基于发展中国家相关案例探索我国制药企业产业升级的突破路径OACSCDCSTPCD
Approaches for Industry Upgrade of Chinese Pharmaceutical Enterprises Based on Relevant Cases from Developing Countries
目的:为我国制药企业在产业升级的过程中尽量避免可能遭遇的问题提供参考.方法:通过收集近年来印度制药企业在产业升级过程中遇到障碍的一些案例,分析其中的原因并对我国制药企业产业升级提出建议.结果与结论:我国制药企业可能要面临专利挑战困难、药品质量事故频发、市场定位不妥和仿创资源分配不平衡等4个比较重大的障碍.建议我国的制药企业在专利问题上与跨国制药公司合作,着眼更高标准的药品质量管理,建立长远海外市场规划,并合理分配仿创资源.
OBJECTIVE: To provide suggestions regarding how to avoid possible problems during the process of entering international market and improving innovation ability. METHODS: Based on collected cases of obstructions that some Indian producers encountered during the process of industry upgrade in recent years and reasons of these obstructions. Some suggestions for Chinese pharmaceutical enterprises were provided. RESULTS & CONCLUSIONS: Patent dispute, drug qua…查看全部>>
赵扬;胡豪;王一涛
中药质量研究国家重点实验室/澳门大学中华医药研究院,澳门特别行政区中药质量研究国家重点实验室/澳门大学中华医药研究院,澳门特别行政区中药质量研究国家重点实验室/澳门大学中华医药研究院,澳门特别行政区
管理科学
制药企业产业升级发展中国家印度中国
Pharmaceutical enterprise Industry upgrade Developing country India China
《中国药房》 2011 (33)
3076-3078,3
澳门大学RC项目(UL016/09-Y1/CMS/WYT01/ICMS)
评论